Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

¥14.52As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002932Healthcare
Country China
PE (Fwd) •••
TSR 8Y CAGR (4.21%)
Div yield —
ROE (1.87%)
Medical Devices
Beta (5Y) 0.40
PE TTM —
TSR TTM (24.49%)
Mkt cap ¥3.050B
ROIC (8.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥16
13.55%
(87.11%)
Hold 12|1|7|11|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.17
0.18
0.18
0.17
14.92%
10.86%
5.96%
4.88%
Revenue¥M
170.8
176.4
182.7
177.6
8.81%
7.11%
7.67%
2.85%
Peers (US$457.2M)
Cap (US$)
PE
474.9M
—
442.6M
25.56x
457.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.758
0.513
0.334
EBIT/Intx
0.292
0.242
0.250
Own earn%
(242.24)
18.96
36.70
Sh yield%
23.41
26.57
25.91
Owners
Insiders/Inst%
7.65
42.30
Short interest%
4.66
SBC / revenue%
5.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
13